Skip to main content

Advertisement

Table 1 Demographic characteristics of the study subjects

From: Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study

  All N = 75488 With tamoxifen N = 50257 Without tamoxifen N = 25231  
Variable n % n % n % p-value
Age, years        <0.0001
<50 35715 47.3 25778 51.3 9937 39.4  
50-59 21676 28.7 13124 26.1 8552 33.9  
60-69 11353 15.0 7001 13.9 4352 17.6  
70+ 6744 8.93 4354 8.66 2390 9.47  
Urbanization        0.34
Urban 50793 67.3 33874 67.4 16919 67.1  
Rural 24695 32.7 16383 32.6 8312 32.9  
Month income, NTD        <0.0001
<= 15000 12795 17.0 8231 16.4 4564 18.1  
15001-20000 39463 52.3 26326 52.4 13137 52.1  
>20000 33230 30.8 15700 31.2 7530 29.8  
Comorbidity        
Hypertension 21882 29.0 14142 28.1 7740 30.7 <0.0001
Hyperlipidemia 15458 20.5 9952 19.8 5506 21.8 <0.0001
Diabetes 8948 11.9 5698 11.3 3250 12.9 <0.0001
PAD 1477 1.96 905 1.80 572 2.27 <0.0001
Stroke 1715 2.27 1012 2.01 703 2.79 <0.0001
Osteoporosis 8024 10.6 5114 10.2 2910 11.5 <0.0001
Medicine, n (%)        
HRT used before the index date 36690 48.6 24487 48.7 12203 48.4 0.35
Aromatase inhibitors used before the end point 20507 27.2 16273 32.4 4234 16.8 <0.0001
  1. Chi-square test
  2. PAD, peripheral artery disease